NO955215L - Nye tricykliske oximetere, fremgangsmåter ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem - Google Patents

Nye tricykliske oximetere, fremgangsmåter ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem

Info

Publication number
NO955215L
NO955215L NO955215A NO955215A NO955215L NO 955215 L NO955215 L NO 955215L NO 955215 A NO955215 A NO 955215A NO 955215 A NO955215 A NO 955215A NO 955215 L NO955215 L NO 955215L
Authority
NO
Norway
Prior art keywords
formula
phenyl
alkyl
carrying
heterocyclic system
Prior art date
Application number
NO955215A
Other languages
English (en)
Norwegian (no)
Other versions
NO955215D0 (no
Inventor
Sylvain Rault
Max Robba
Jean-Charles Lancelot
Herve Prunier
Pierre Renard
Bruno Pfeiffer
Beatrice Guardiola-Lemaitre
Marie-Claire Rettori
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO955215D0 publication Critical patent/NO955215D0/no
Publication of NO955215L publication Critical patent/NO955215L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Indole Compounds (AREA)
NO955215A 1994-12-22 1995-12-21 Nye tricykliske oximetere, fremgangsmåter ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem NO955215L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9415431A FR2728571B1 (fr) 1994-12-22 1994-12-22 Nouveaux ethers d'oximes tricycliques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
NO955215D0 NO955215D0 (no) 1995-12-21
NO955215L true NO955215L (no) 1996-06-24

Family

ID=9470078

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955215A NO955215L (no) 1994-12-22 1995-12-21 Nye tricykliske oximetere, fremgangsmåter ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem

Country Status (17)

Country Link
US (1) US5627203A (de)
EP (1) EP0718299B1 (de)
JP (1) JP2937837B2 (de)
CN (2) CN1066449C (de)
AT (1) ATE191483T1 (de)
AU (1) AU693615B2 (de)
CA (1) CA2165618C (de)
DE (1) DE69516100T2 (de)
DK (1) DK0718299T3 (de)
ES (1) ES2147271T3 (de)
FI (1) FI956136L (de)
FR (1) FR2728571B1 (de)
GR (1) GR3033507T3 (de)
NO (1) NO955215L (de)
NZ (1) NZ280734A (de)
PT (1) PT718299E (de)
ZA (1) ZA9510901B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2781482B1 (fr) * 1998-07-27 2001-08-31 Adir Nouveaux derives de 8h-thieno-[2,3-b]pyrrolizine-8-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU2003294275A1 (en) * 2002-11-21 2004-06-18 New York Blood Center Compounds for inhibition of hiv infection by blocking hiv entry
DE102008015033A1 (de) * 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung
DE102008015032A1 (de) * 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte Pyrazolamide und ihre Verwendung
DE102008062878A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte Furancarboxamide und ihre Verwendung
DE102008062863A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE371193B (de) * 1972-03-24 1974-11-11 Kabi Ab
US4308399A (en) * 1977-08-30 1981-12-29 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. O-(3-Amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
US4134894A (en) * 1978-05-04 1979-01-16 Warner-Lambert Company Pyrrolo[1,2-a]indole compounds
HU180739B (en) * 1979-07-03 1983-04-29 Egyt Gyogyszervegyeszeti Gyar Process for producing basic oxime-ethers
US5128364A (en) * 1991-03-28 1992-07-07 Merck Frosst Canada, Inc. Pyrrolo[1,2-a]indole hydroxylamine derivatives as inhibitors of leukotriene biosynthesis

Also Published As

Publication number Publication date
US5627203A (en) 1997-05-06
FR2728571A1 (fr) 1996-06-28
DE69516100T2 (de) 2000-12-14
CN1066449C (zh) 2001-05-30
DK0718299T3 (da) 2000-09-04
AU693615B2 (en) 1998-07-02
ES2147271T3 (es) 2000-09-01
FI956136A7 (fi) 1996-06-23
GR3033507T3 (en) 2000-09-29
JPH08231554A (ja) 1996-09-10
JP2937837B2 (ja) 1999-08-23
EP0718299A1 (de) 1996-06-26
NZ280734A (en) 1997-09-22
CA2165618A1 (fr) 1996-06-23
CN1261073A (zh) 2000-07-26
AU4059395A (en) 1996-06-27
ATE191483T1 (de) 2000-04-15
PT718299E (pt) 2000-07-31
FR2728571B1 (fr) 1997-01-31
NO955215D0 (no) 1995-12-21
FI956136L (fi) 1996-06-23
CA2165618C (fr) 2001-04-10
CN1131155A (zh) 1996-09-18
ZA9510901B (en) 1996-06-24
EP0718299B1 (de) 2000-04-05
DE69516100D1 (de) 2000-05-11
FI956136A0 (fi) 1995-12-20

Similar Documents

Publication Publication Date Title
ES2137113A1 (es) Nuevos derivados de triazolo-piridazinas heterociclicos.
MX9804247A (es) Derivados de quinazolina.
CA2551867A1 (en) Control of parasites in animals by the use of imidazo[1,2-b]pyridazine derivatives
HUP0402336A2 (hu) Tieno[2,3-d]pirimidin-2,4-dion-származékok, eljárás előállításukra, alkalmazásuk autoimmun betegségek modulálására és a vegyületeket tartalmazó gyógyszerkészítmények
IE782493L (en) Phosphonoformic acid derivatives
NZ512731A (en) Tricyclic inhibitors of poly(ADP-ribose) polymerases
IE812273L (en) Cephalosporin derivatives
RU2005135338A (ru) Замещенные 3-цианотиофенацетамиды в качестве антагонистов рецептора глюкагона
TW375615B (en) Galanthamine derivatives and their use as medicaments
NO960441L (no) Benzopyraner og farmasöytiske forbindelser inneholdende dem
KR950702563A (ko) 테트라시클릭 화합물, 이것의 제조방법 및 중간체와, 항암제로서의 이들의 사용방법(tetracyclic compounds process and intermediates for their preparation and their use as antitumour agents)
EA200001101A1 (ru) НОВЫЕ ДИГИДРОФУРО[3,4-b]ХИНОЛИН-1-ОНЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
NO950360L (no) Nytt legemiddel som inneholder 3-fenylsulfonyl-3,7-diazabisyklo[3,3,1Ånonan-forbindelser
ATE42292T1 (de) Imidazo(1,2-c)pyrimidine und ihre salze, verfahren zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen.
AU703163B2 (en) Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions
HU896551D0 (en) Process for the preparation of aryloxy-, arylthio-, heteroaryloxy- and heteroarylthio-alkenylene derivatives of amines and pharmaceutical compositions containing them
HU9503718D0 (en) Serotoninergic abeo-ergoline derivatives
NO982549L (no) 5-naftalen-1-yl-1,3-dioksan-derivater, fremstilling og terapeutisk anvendelse derav
NZ330832A (en) 5-heterocyclyl-alkyl-3-oxo-N-(heteroaryl or aryl)-pyrido[1,2-a]benzimidazole-4-carboxamide derivatives and medicaments
KR880008991A (ko) 축합된 피라졸 유도체 및 이의 제조방법
IE45587L (en) Diazepinoheterocyclic compounds
NZ320174A (en) 4a,5a,8a,8b-tetrahydro-6H-pyrrolo[3,4':4,5]furo(3,2-b)pyridine-6,8-[7H]- dione derivatives useful for controlling endoparasites
MY138045A (en) New benzo[b]pyrano[3,2-h]acridin-7-one cinnamate compounds, a process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application